AUTORIZZAZIONE ALLO SVOLGIMENTO PRESSO LA U.O.S.D. SPRERIMENTAZIONI DI FASE IV DELL’ISTITUTO NAZIONALE TUMORI REGINA ELENA DELLA SPERIMENTAZIONE DAL TITOLO: “STUDIO OSSERVAZIONALE PROSPETTICO, MULTICENTRICO, MULTINAZIONALE, DI PAZIENTI CHE INIZIANO IL TRATTAMENTO CON T-DXD NELLA PRIMA O SECONDA LINEA DI TRATTAMENTO PER IL CARCINOMA MAMMARIO HER2+ E HER2-LOW NON RESECABILE E/O METASTATICO” PROT. D9673R00025 ED APPROVAZIONE DEL CONTRATTO CON PAREXEL INTERNATIONAL (IRL) LIMITED IN NOME E PER CONTO DI ASTRA ZENECA AB RESPONSABILE: Dott.ssa Patrizia Vici Registro Sperimentazioni N. 37/IRE/23
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.